MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s40478-026-02419-3

Медицинская библиотека · Acta neuropathologica communications · 2026

The superior prognostic role of pRB1 over p16 immunohistochemistry as a biomarker in meningiomas.

Gött Hanna, Tellermann Jonas, Becker Hannes, Fodi Christina, Paßlack Peter, Hoffmann Elgin, Di Francesco Maria Elisa, Merk Daniel J, Honegger Jürgen, Tabatabai Ghazaleh, Tatagiba Marcos, Behling Felix, Schittenhelm Jens

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Despite best clinical management, patients with meningiomas frequently experience tumor recurrence. During recent decades, efforts have been made to improve the prognostic stratification of meningiomas by incorporating molecular data. A subgroup of tumors harboring a homozygous CDKN2A deletion was identified, and a higher risk of tumor progression was observed, suggesting the potential use of cyclin-dependent kinases as biomarkers.

MATERIAL AND

METHODS

In this retrospective single-center study, the immunohistochemical staining for the cyclin-dependent kinases p16, phosphoRB1 (pRB1), CDK4 and CDK6 was analyzed in 1751 paraffin-embedded meningioma samples. For the assessment of p16, CDK4 and CDK6, a semi-quantitative score was applied, whereas an automated quantification tool was used for pRB1. The distribution and association with histopathological results, clinical data and progression-free survival (PFS)-defined by radiographic tumor recurrence-were assessed.

RESULTS

Of all meningioma samples, 14.9% (n = 261) expressed p16. Elevated pRB1 levels were found in 34.5% (n = 589) of tumor samples. CDK4 and CDK6 positive staining was observed in 41.9% and 42.2% of cases, respectively. Dichotomous stratification of meningiomas based on p16 and pRB1 expression levels suggested a significant influence on PFS in univariate analyses. Multivariate analysis determined elevated pRB1 expression, WHO grading, extent of resection, adjuvant radiotherapy, male gender, NF2-status and an elevated MIB1 index as independent prognostic factors.

CONCLUSIONS

High expression of pRB1 is an independent prognostic factor for shorter PFS. The prognostic impact of p16 is mostly attributed to the confounding increase of pRB1 expression.

Для цитирования: Gött Hanna, Tellermann Jonas, Becker Hannes, Fodi Christina, Paßlack Peter, Hoffmann Elgin, Di Francesco Maria Elisa, Merk Daniel J, Honegger Jürgen, Tabatabai Ghazaleh, Tatagiba Marcos, Behling Felix, Schittenhelm Jens. The superior prognostic role of pRB1 over p16 immunohistochemistry as a biomarker in meningiomas.. Acta neuropathologica communications. 2026. DOI: 10.1186/s40478-026-02419-3.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.